Aethlon Medical (NASDAQ: AEMD) reported Q4 EPS of ($0.65), $0.45 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $659 thousand versus the consensus estimate of $370 thousand.

For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.